This was 2 years ago
LocationOnline
ProgrammesThe first European Mission Forum (EMiF) will take place early next year. The Forum will provide a platform for information and interactive exchange to support all stakeholders at European, national and regional level in the successful implementation of the EU Missions.
The event will introduce the European Mission Network EMiN to a wider public and offer participants an opportunity to learn about other EU-Mission actors from outside their usual networks. On the Forum's agenda:
More information on the 1st Forum, the detailed programme and registration can be found here.
Background: The European Mission Network (EMiN), is created as an emerging community of practice that connects key players from the business sector, academia, civil society organisations as well as governmental actors. The EMiN will act as central information and exchange platform for the benefit of EU Missions actors across Europe and across EU Missions. Besides offering exchange and learning formats to its members, its aim is to bundle expertise, experiences, scientific findings and practical examples of adaptation to the mission environment. More information on EMiN (membership) can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.